Two Abstracts by The Center for Innovative GYN Care Selected for Presentation at the 2019 Society of Gynecologic Surgeons Annual Meeting

Monday, April 1, 2019 Press Release
Email Print This Page Comment bookmark
Font : A-A+

New Data on Effectiveness and Safety of Laparoscopic-Assisted Myomectomy to be Highlighted

WASHINGTON, April 1, 2019  /PRNewswire/ -- The Center for Innovative GYN Care® (CIGC®) founders, Dr.

Paul MacKoul and Dr. Natalya Danilyants, announced today that two Company abstracts have been accepted for presentation at this year's Society of Gynecologic Surgeons (SGS) Annual Scientific Meeting. The presentations, titled "Laparoscopic-Assisted Myomectomy with Uterine Artery Ligation at The Origin: Outcomes From A Series Of 184 Cases" and "Laparoscopic-Assisted Myomectomy With Reversible Uterine Artery Occlusion: Outcomes From A Series Of 404 Cases," will be available on April 1 at 6:30 a.m. to 3:30 p.m. local time in the Arizona Foyer at the JW Marriott Starr Pass in Tucson.

The results of CIGC's first analysis demonstrate that laparoscopic-assisted myomectomy (LAM) with early uterine artery ligation at the origin is an effective, safe procedure for the removal of all types of uterine myoma, with the ability to control blood loss and remove a significant tumor load. This study analyzed a total of 184 consecutive patients who underwent LAM with retroperitoneal dissection, uterine artery ligation at the origin at the anterior branch of the internal iliac artery and a mini-laparotomy for specimen removal. The mean myoma weight removed was 546 g, with a mean operative time of 68 minutes and estimated blood loss of 264 mL. The types of myoma removed were subserosal (21 percent), intramural (41 percent), and submucosal (28 percent).

In addition, CIGC's second analysis found that LAM with reversible occlusion of the uterine arteries using a tourniquet around the isthmus of the uterus is an effective procedure for the removal of uterine myoma, with the ability to also control blood loss and remove a significant tumor load. The study analyzed a total of 404 consecutive patients who underwent LAM with placement of a laparoscopic latex tourniquet around the isthmus of the uterus, causing a temporary occlusion of the utero-ovarian pedicle and a mini-laparotomy for specimen removal. The mean myoma weight removed was 323 g, with a mean operative time of 62 minutes and estimated blood loss of 171 mL. The types of myoma removed were subserosal (11 percent), intramural (16 percent), and submucosal (20 percent).

All of the women in both of these studies were 18 years or older, non-pregnant and had benign indications for surgery. All cases were performed by two surgeons at a single practice in a freestanding ambulatory surgery center (ASC), and no power morcellation was used in any cases. CIGC's practice consists of two minimally invasive gynecologic surgical specialists who individually performed each of these procedures.

"The data collected from these studies are powerful reinforcements of both the true safety and efficacy of laparoscopic-assisted myomectomy," said Dr. Louise van der Does, CIGC's Director of Research and Public Policy. "It is CIGC's mission as an innovative gynecological surgical practice to provide access to these types of treatments for as many women in need as possible and equip patients with the knowledge to help them make the best gynecological decisions for themselves. Many women continue to undergo open surgery or costly robotic procedures despite clear evidence showing that minimally invasive procedures, such as those performed by the highly experienced specialists at CIGC, provide better outcomes and quality of life after surgery."

The SGS 45th Annual Scientific Meeting will take place from March 31 through April 3, 2019. The conference features a diverse program of panel discussions, seminars and educational programs aimed at promoting excellence in gynecologic surgery, as well as the advancement of basic and clinical research, professional and public education.

About The Center for Innovative GYN CareThe Center for Innovative GYN Care® (CIGC®) is a state-of-the-art laparoscopic GYN surgical practice that uses exclusive techniques developed by the founders, Dr. Paul MacKoul and Dr. Natalya Danilyants. Patients travel from around the world for the groundbreaking DualPortGYN® and LAAM-BUAO® techniques. These innovations treat complex gynecologic conditions using just two small incisions without the use of power morcellation or robotics. The practice is dedicated to providing women with excellent laparoscopic outpatient surgical care that optimizes the procedure, minimizes the risk of complications and ensures a faster recovery at home.

Cision View original content:http://www.prnewswire.com/news-releases/two-abstracts-by-the-center-for-innovative-gyn-care-selected-for-presentation-at-the-2019-society-of-gynecologic-surgeons-annual-meeting-300821444.html

SOURCE The Center for Innovative GYN Care



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store